Table 3

Risk of recent symptoms (physical and psychological) and drug use in a population exposed to the Eyjafjallajökull volcanic eruption compared to a non-exposed population

Non-exposedExposed
% (n/N)% (n/N)OR (95% CI)*p Value
Respiratory symptoms†
 Shortness of breath3.5 (17/488)6.7 (72/1074)2.1 (1.2 to 3.6)0.011
 Feeling of tightness in chest1.8 (9/491)3.6 (38 /1070)2.5 (1.1 to 5.8)0.03
Cough and phlegm†
 Cough6.4 (31/488)15.3 (166/1085)2.6 (1.7 to 3.9)<0.001
 Phlegm5.5 (27/488)11.3 (122/1079)2.1 (1.3 to 3.2)<0.001
Irritation symptoms†
 Dry throat3.4 (17/494)10.1 (110/1089)3.1 (1.8 to 5.3)<0.001
 Eye irritation and itch8.6 (42/487)20.6 (224/1085)2.9 (2.0 to 4.1)<0.001
 Skin rash/eczema5.1 (25/487)6.2 (67/1075)1.2 (0.8 to 1.9)0.39
Musculoskeletal symptoms†
 Back pain23.0 (116/494)18.2 (196/1075)0.7 (0.5 to 0.9)0.012
 Myalgia24.2 (120/496)20.1 (216/1073)0.7 (0.6 to 1.0)0.024
Sleep† and mental health
 Insomnia16.9 (84/497)13.7 (148/1078)0.8 (0.6 to 1.0)0.08
 Psychological morbidity‡19.0 (95/500)24.6 (278/1129)1.3 (1.0 to 1.7)0.05
Regular drugs use (at least once per week)
 Asthma medication4.7 (24/510)3.4 (39/1147)0.7 (0.4 to 1.1)0.12
 Analgesics11.4 (58/510)8.7 (100/1147)0.7 (0.5 to 1.0)0.04
 Any drug for depression, anxiety, sleeping and other mental symptoms14.9 (76/510)12.5 (144/1148)0.8 (0.6 to 1.1)0.12
 Blood pressure-lowering medication19.6 (100/510)22.6 (259/1148)1.3 (1.0 to 1.7)0.10
  • *OR and 95% CI from multivariate logistic regression adjusted for age category, gender, education and smoking status.

  • †Answers ‘Yes, to a moderate extent’ or ‘Yes, to much extent’ to the question ‘Have any of the following symptoms disturbed your daily activities during the last month?’.

  • ‡Psychological morbidity was derived from GHQ-12 referring to ‘the previous weeks’, using a binary cut-off score of >2.